ASPMN® Position Statements
Guidelines on Monitoring for Opioid-Induced Sedation and Respiratory Depression: Revisions (Approved June 2019)
“Pain Assessment in the Patient Unable to Self-Report” (Approved: 2019)
“As-Needed” Range Orders for Opioid Analgesics in the Management of Pain: A Consensus Statement of the American Society for Pain Management and the American Pain Society – This is a joint statement from: American Society for Pain Management Nursing® and American Pain Society (Approved: 2018)
- Authorized Agent Controlled Analgesia – A position paper with clinical practice guidelines (Approved: August 2013)
- Pain Management at the End of Life (Revised: October 2017, Orginally approved: August 2013)
- Male Infant Circumcision Pain Management (Revised July 2021)
- Monitoring for Opioid-Induced Advancing Sedation and Respiratory Depression in Adults (Revised August 2021)
- Deceptive Use of Placebos in the Assessment and Management of Pain (Revised July 2021)
- **New**Procedural Pain Management Position Statement (Revised 2022)
- Registered Nurse Management and Monitoring of Analgesia By Catheter Techniques
**New** Prescribing and Administering Opioid Doses Based Solely on Pain Intensity: Update of a Position Statement by the American Society for Pain Management Nursing (Revised February 2022)